Hepatic Encephalopathy Clinical Trials

A listing of Hepatic Encephalopathy medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294-0111

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Arizona

Phoenix Arizona 85054

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Tucson Arizona 85724

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Arkansas

Little Rock Arkansas 72205

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

California

Coronado California 92118

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Coronado California 92118

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

La Jolla California 92037

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Loma Linda California 92324

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Los Angeles California 90048

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

View More ▼

Los Angeles California 90033

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Los Angeles California 90033

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Los Angeles California 90048

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Rialto California 92377

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

San Francisco California 94115

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Colorado

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Connecticut

New Haven Connecticut 06504

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Florida

Miami Florida 33136

A clinical trial seeking patients for a research study for the treatment of Hepatic Encephalopathy

Miami Florida 33136

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Georgia

Atlanta Georgia 30322

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Atlanta Georgia 30309

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Atlanta Georgia 30309

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Illinois

Chicago Illinois 60611

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Chicago Illinois 60612

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Chicago Illinois 60637

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating 13C-methacetin for the treatment of Acute Liver Failure

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

View More ▼

Chicago Illinois 60611

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Glenview Illinois 60026

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Iowa

Iowa City Iowa 52242

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Louisiana

New Orleans Louisiana 70121

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

New Orleans Louisiana 70112

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

New Orleans Louisiana 70112

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Maryland

Baltimore Maryland 21287

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Bethesda Maryland 20814

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Massachusetts

Boston Massachusetts 02215

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Minnesota

Minneapolis Minnesota 55455

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Mississippi

Jackson Mississippi 39216

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Missouri

Columbia Missouri 65212

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

New Jersey

Newark New Jersey 07103

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

New York

New York New York 10029

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

New York New York 10032

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

New York New York 10016

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

New York New York 10021

Patients are needed to participate in a clinical research study of Rifaximin (drug) to evaluate Hepatic Encephalopathy, Hepatitis C or Liver Cirrhosis

North Carolina

Chapel Hill North Carolina 27514

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Ohio

Columbus Ohio 43210

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Columbus Ohio 43210

Patients are needed to participate in a clinical research study evaluating 13C-methacetin for the treatment of Acute Liver Failure

Pennsylvania

Philadelphia Pennsylvania 19104

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy

Philadelphia Pennsylvania 19107

A Phase 2 clinical study for patients with Acute Episode of Overt Hepatic Encephalopathy or Hepatic Encephalopathy